findmyKOL
Clinical trialNCT01269242CompletedPhase 2Interventional

The Effects of Bindarit in Preventing Stent Restenosis

SponsorAziende Chimiche Riunite Angelini Francesco S.p.AEnrollment148Coronary Restenosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Antonio Colombo, MD

    Fondazione S.Raffaele del Monte Tabor - U.O Emodinamica e Cardiologia Interventistica

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Italy
  • Fondazione S.Raffaele del Monte Tabor - Uo Emodinamica E Cardiologia Interventistica

    Milan, Milan, Italy

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2009
Primary completion
31 Jan 2011
Completion
30 Apr 2011
Last update posted
5 Aug 2016
Registered enrollment
148
Registry id
NCT01269242

Cross-registrations

EU-CTR / CTIS (EudraCT)2008-004921-40

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.